Rochester, MN, United States of America

David Holms

This inventor holds 1 USPTO granted patent. Top assignee: Tricardia, LLC. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Holms. Retrieved from https://idiyas.com/inventor/david-holms

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of David Holms

Introduction

David Holms is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical devices, particularly in the area of hemostatic agents. His work focuses on improving the safety and efficiency of catheterization procedures.

Latest Patents

David Holms holds a patent for a hemostatic agent delivery device that features a built-in pressure sensor. This innovative instrument is designed to achieve rapid hemostasis at the conclusion of a catheterization procedure. The device includes an elongated tubular member with ejection ports near its distal end, allowing for precise delivery of a hemostatic agent. The design incorporates a hub member with a transparent cover that provides visual feedback on blood flow, ensuring that the device is correctly positioned within the blood vessel.

Career Highlights

Throughout his career, David has demonstrated a commitment to advancing medical technology. His patent reflects a deep understanding of the challenges faced during catheterization procedures and offers a practical solution to enhance patient outcomes. He is currently associated with Tricardia, LLC, where he continues to innovate in the medical device sector.

Collaborations

David has worked alongside esteemed colleagues, including Robert A Van Tassel and Robert S Schwartz. Their collaborative efforts contribute to the development of cutting-edge medical technologies that aim to improve patient care.

Conclusion

David Holms is a distinguished inventor whose work in developing a hemostatic agent delivery device showcases his dedication to medical innovation. His contributions are poised to make a lasting impact on the field of catheterization and patient safety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…